Computational modeling of cardiac disease: Potential for personalized medicine

Personalized Medicine

Volumn 6, Issue 1, 2009, Pages 45-66

  Reumann, Matthias ^a   Gurev, Viatcheslav ^b   Rice, John Jeremy ^a,b  

^a IBM T J WATSON RESEARCH CENTER   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Cardiology; Cardiovascular disease electromechanical models; Channelopathies; Defomation models; Electrophysiological models

Indexed keywords

POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ; POTASSIUM ION; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM ION;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIAC CHANNELOPATHY; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE POTENTIAL; ELECTROCARDIOGRAPHY; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART VENTRICLE; HIDDEN MARKOV MODEL; HUMAN; LONG QT SYNDROME; MATHEMATICAL MODEL; MEDICAL PRACTICE; PERSONALIZED MEDICINE; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; SHORT QT SYNDROME; SODIUM CURRENT; THREE DIMENSIONAL IMAGING;

EID: 67651121631     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/17410541.6.1.45     Document Type: Review

References (128)

1. American Heart Association: Heart Disease and Stroke Statistics - 2008 Update. American Heart Association, USA (2008).
2. Arking DE, Chugh SS, Chakravarti A, Spooner PM: Genomics in sudden cardiac death. Circ. Res. 94, 712-723 (2004).
3. Nass RD, Aiba T, Tomaselli GF, Akar FG: Mechanisms of disease: ion channel remodeling in the failing ventricle. Nat. Clin. Pract. Cardiovasc. Med. 5, 196-207 (2008).
4. Swynghedauw B: Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79, 215-262 (1999).
5. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N. Engl. J. Med. 321, 406-412 (1989).
6. Vassallo P, Trohman RG: Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 298, 1312-1322 (2007).
7. Amiodarone hydrochloride (marketed as Cordarone) information. US FDA (2008).
8. Hodgkin AL, Huxley AF: A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117, 500-544 (1952).
9. 2+ release. Biopbys. J. 83, 2918-2945 (2002).
10. Hussan J, De Tombe PP, Rice JJ: A spatially detailed myofilament model as a basis for large-scale biological simulations. IBM J. Res. Dev. 50, 583-600 (2006).
11. Greenstein JL, Hinch R, Winslow RL: Mechanisms of excitation-contraction coupling in an integrative model of the cardiac ventricular myocyte. Biophys. J. 90, 77-91 (2006).
12. Rice JJ, Kohl P: The response of cardiac muscle to stretch: the role of calcium. In: Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention. Gussak I, Antzelevitch C, Wilde AAM, Friedman PA, Ackerman MJ, Shen WK (Eds). Springer-Verlag, London, UK (2008).
13. Kerckhoffs RC, Narayan SM, Omens JH, Mulligan LJ, McCulloch AD: Computational modeling for bedside application. Heart Fail. Clin. 4, 371-378 (2008).
14. Sermesant M, Peyrat JM, Chinchapatnam P et al.: Toward patient-specific myocardial models of the heart. Heart Fail. Clin. 4, 289-301 (2008).
15. Rudy Y, Silva JR: Computational biology in the study of cardiac ion channels and cell electrophysiology. Q Rev. Biophys. 39, 57-116 (2006).
16. + channel model versus the five-state Markovian model. Biopolymers 31, 1483-1502 (1991).
17. + current. Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96, 195-215 (1990).
18. Viswanathan PC, Shaw RM, Rudy Y: Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation 99, 2466-2474 (1999).
19. Silva J, Rudy Y: Subunit interaction determines IKs participation in cardiac repolarizarion and repolarization reserve. Circulation 112, 1384-1391 (2005).
20. Clancy CE, Rudy Y: Na+ channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 105, 1208-1213 (2002).
21. Clancy CE, Rudy Y: Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 400, 566-569 (1999).
22. 2+ dynamics: the roles of ryanodine receptor adaptation and sarcoplasmic reticulum load. Biophys. J. 74, 1149-1168 (1998).
23. 2+ channel. Cell 133, 1228-1240 (2008).
24. 2+. Structure 16, 607-620 (2008).
25. Brugada J, Brugada R, Brugada P: Channelopathies: a new category of diseases causing sudden death. Herz 32, 185-191 (2007).
26. Wilde AA: Channelopathies in children and adults. Pacing Clin. Electrophysiol. 31(Suppl. 1), S41-S45 (2008).
27. Priori SG: Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ. Res. 94, 140-145 (2004).
28. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC: Compound mutations: a common cause of severe long-QT syndrome. Circulation 109, 1834-1841 (2004).
29. +-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl Acad. Sci. USA 93, 2208-2212 (1996).
30. Anderson CL, Delisle BP, Anson BD et al.: Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113, 365-373 (2006).
31. Bellocq C, Van Ginneken AC, Bezzina CR et al.: Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109, 2394-2397 (2004).
32. Brugada R, Hong K, Dumaine R et al.: Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109, 30-35 (2004).
33. Peitersen T, Grunnet M, Benson AP, Holden AV, Holstein-Rathlou NH, Olesen SP: Computational analysis of the effects of the hERG channel opener NS1643 in a human ventricular cell model. Heart Rhythm 5, 734-741 (2008).
34. Rudy Y: From genetics to cellular function using computational biology. Ann. NY Acad. Sci. 1015, 261-270 (2004).
35. 2+ channel mutations and T-wave alternans: a model study. Am. J. Physiol. Heart Circ. Physiol. 293, H3480-H3489 (2007).
36. Viswanathan PC, Rudy Y: Cellular arrhythmogenic effects of congenital and acquired long-QT syndrome in the heterogeneous myocardium. Circulation 101, 1192-1198 (2000).
37. Gima K, Rudy Y: Ionic current basis of electrocardiographic waveforms: a model study, Circ. Res. 90, 889-896 (2002).
38. Clancy CE, Zhu ZI, Rudy Y: Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation. Am. J. Physiol. Heart Circ. Physiol. 292, H66-75 (2007).
39. Mazhari R, Greenstein JL, Winslow RL, Marban E, Nuss HB: Molecular interactions between two long-QT syndrome gene products, HERG and KCNE2, rationalized by in vitro and in silico analysis. Circ. Res. 89, 33-38 (2001).
40. Clancy CE, Rudy Y: Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death. Cardiovasc. Res. 50, 301-313 (2001).
41. Alonso-Atienza F, Requena-Carrion J, Rojo-Alvarez JL, Berenfeld O, Jalife J: Action potential alternans in LQT3 syndrome: a simulation study. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 640-643 (2007).
42. Antzelevitch C, Shimizu W, Yan GX et al.: The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J. Cardiovasc. Electrophysiol. 10, 1124-1152 (1999).
43. Akar FG, Yan GX, Antzelevitch C, Rosenbaum DS: Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome. Circulation 105, 1247-1253 (2002).
44. Keller DU, Seemann G, Weiss DL, Farina D, Zehelein J, Dossel O: Computer based modeling of the congenital long-QT 2 syndrome in the Visible Man torso: from genes to ECG. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 1410-1413 (2007).
45. Yan GX, Antzelevitch C: Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 98, 1928-1936 (1998).
46. Brennan TP, Fink M, Stokeley D, Rodriguez B, Tarassenk L: Modelling effects of sotalol on T-wave morphology. Computers Cardiol. 2007, 249-252 (2007).
47. Plonsey R, Barr RC: Bioelectricity: a quantitative approach. Plenum, New York, NY, USA (1988).
48. Pullan A, Buist ML, Cheng LK: Mathematically Modelling the Electrical Activity of the Heart. World Scientific Publishing Co. Pte. Ltd., NJ, USA (2005).
49. Sundnes J, Lines GT, Cai X, Nielsen BF, Mardal KA, Tveito A: computing the electrical activity in the heart. In: Monographs in Computational Science and Engineering Barth TJ, Griebel M, Keyes DE, Nieminen RM, Roose D, Schlick T (Fds). Heidelberg: Springer Verlag, Berlin, Germany (2006).
50. Vigmond EJ, Clements C, McQueen DM, Peskin CS: Effect of bundle branch block on cardiac output: a whole heart simulation study. Prog. Biophys. Mol. Biol. 97, 520-542 (2008).
51. Potse M, Dube B, Richer J, Vinet A, Gulrajani RM: A comparison of monodomain and bidomain reaction-diffusion models for action potential propagation in the human heart. IEEE Trans. Biomed. Eng. 53, 2425-2435 (2006).
52. Potse M, LeBlanc AR, Vinet A: Why do we need supercomputers to understand the electrocardiographic T wave? Anadolu. Kardiyol. Derg. 7(Suppl. 1), 123-124 (2007)
53. Pitt-Francis J, Bernabeu MO, Cooper J et al.: Chaste: using agile programming technique to develop computational biology software. Philos. Transact. A Math. Phys. Eng. Sci. 366, 3111-3136 (2008).
54. Pitt-Francis J, Garny A, Gavaghan D: Enabling computer models of the heart for high-performance computers and the grid. Philos. Transact. A Math. Phys. Eng. Sci. 364, 1501-1516 (2006).
55. Southern J, Pitt-Francis J, Whiteley J et al.: Multi-scale computational modelling in biology and physiology. Prog. Biophys. Mol. Biol. 96, 60-89 (2008).
56. Reumann M, Fitch BG, Rayshubskiy A et al.: Large scale cardiac modeling on the blue gene supercomputervancouver. In: 30th Annual International IEEE EMBS Conference. IEEE Press, British Columbia, Canada (2008).
57. Plank G, Zhou L, Greenstein JL et al.: From mitochondrial ion channels to arrhythmias in the heart: computational techniques to bridge the spatio-temporal scales. Philos. Transact. A Math. Phys. Eng. Sci. 366, 3381-3409 (2008).
58. Maharaj T, Blake R, Trayanova N, Gavaghan D, Rodriguez B: The role of transmural ventricular heterogeneities in cardiac vulnerability to electric shocks. Prog. Biophys. Mol. Biol. 96, 321-338-(2008).
59. Trayanova NA: The long and the short of long and short duration ventricular fibrillation. Circ. Res. 102, 1151-1152 (2008).
60. Rodriguez B, Trayanova N, Noble D: Modeling cardiac ischemia. Ann. NY Acad. Sci. 1080, 395-414 (2006).
61. Boyle PM, Deo M, Vigmond EJ: Behaviour of the purkinje system during defibrillation- strength shocks. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 419-422 (2007).
62. ten Tusscher, KH, Noble D, Noble PJ, Panfilov AV: A model for human ventricular tissue. Am. J. Physiol. Heart Circ. Physiol. 286, H1573-H1589 (2004).
63. Ramanathan C, Ghanem RN, Jia P, Ryu K, Rudy Y: Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat. Med. 10, 422-428 (2004).
64. Rudy Y: Modelling and imaging cardiac repolarization abnormalities. J. Intern. Med. 259, 91-106 (2006).
65. Marban E: Cardiac channelopathies. Nature 415, 213-218 (2002).
66. Winslow RL, Rice J, Jafri S: Modeling the cellular basis of altered excitation-contraction coupling in heart failure. Prog Biophys. Mol. Biol. 69, 497-514 (1998).
67. Winslow RL, Rice J, Jafri S, Marban E, O'Rourke B: Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. Circ. Res. 84, 571-586 (1999).
68. Gao Z, Xu H, DiSilvestre D et al.: Transcriptomic profiling of the canine tachycardia-incluced heart failure model: global comparison to human and murine heart failure. J. Mol. Cell Cardiol. 40, 76-86 (2006).
69. Kumar N, Hendriks BS, Janes KA, de Graaf D, Lauffenburger DA: Applying computational modeling to drug discovery and development. Drug Discov. Today 11, 806-811 (2006).
70. Wolf-Yadlin, A, Hautaniemi S, Lauffenburger DA, White FM: Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl Acad. Sci. USA 104, 5860-5865 (2007).
71. Janes KA, Albeck JG, Peng LX, Sorger PK, Lauffenburger DA, Yaffe MB: A high-throughput quantitative multiplex kinase assay for monitoring information flow in signaling networks: application to sepsis-apoptosis. Mol. Cell Proteomics 2, 463-473 (2003).
72. Goldenberg I, Moss AJ: Long QT syndrome. J. Am. Coll. Cardiol. 51, 2291-2300 (2008).
73. Simon-Sanchez, J, Scholz S, Matarin Mdel M et al.: Genomewide SNP assay reveals mutations underlying Parkinson disease. Hum. Mutat. 29, 315-322 (2008).
74. Foody JM, Farrell MH, Krumholz HM: β-blocker therapy in heart failure: scientific review. JAMA 287, 883-889 (2002).
75. Saucerman JJ, Brunton LL, Michailova AP, McCulloch AD: Modeling β-adrenergic control of cardiac myocyte contractility in silico. J. Biol. Chem. 278, 47997-48003 (2003).
76. Maly IV, Lee RT, Lauffenburger DA: A model for mechanotransduction in cardiac muscle: effects of extracellular matrix deformation on autocrine signaling. Ann. Biomed. Eng. 32, 1319-1335 (2004).
77. Bucci MK, Bevan A, Roach M, 3rd: Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J. Clin. 55, 117-134 (2005).
78. Evans PM: Anatomical imaging for radiotherapy. Phys. Med. Biol. 53, R151-R191 (2008).
79. Meyer JL, Verhey L, Xia P, Wong J: New technologies in the radiotherapy clinic. Front Radiat. Ther. Oncol. 40, 1-17 (2007).
80. Ibbott GS, Followill DS, Molineu HA, Lowenstein JR, Alvarez PE, Roll JE: Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 71, S71-S75 (2008).
81. Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, Stolovitzky GA: A plausible model for the digital response of p53 to DNA damage. Proc. Natl Acad. Sci. USA 102, 14266-14271 (2005).
82. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S et al.: Oscillations and variability in the p53 system. Mol. Syst. Biol. 2, 0033 (2006).
83. Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I: Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys. J. 90, 1546-1559 (2006).
84. Christopher R, Dhiman A, Fox J et al.: Data-driven computer simulation of human cancer cell. Ann. NY Acad. Sci. 1020, 132-153 (2004).
85. South CP, Partridge M, Evans PM: A theoretical framework for prescribing radiotherapy dost distributions using patient-specific biological information. Med. Phys. 35, 4599-4611 (2008).
86. Kerckhoffs RCP, Healy SH, Usyk TP, McCulloch AD: Computational methods for cardiac electromechanics. Proc. IEEE 94, 769-783 (2006).
87. Hunter P, Smith N, Fernandez J, Tawhai M: Integration from proteins to organs: the IUPS Physiome Project. Mech. Ageing Dev. 126, 187-192 (2005).
88. Hunter P, Robbins P, Noble D: The IUPS human Physiome Project. Pflugers Arch. 445, 1-9 (2002).
89. Hunter PJ, Pollan AJ, Smaill BH: Modeling total heart function. Annu. Rev. Biomed. Eng. 5, 147-177 (2003).
90. Rice JJ, De Tombe PP: Approaches to modeling crossbridges and calcium-dependent activation in cardiac muscle. Prog. Biophys. Mol. Biol. 85, 179-195 (2004).
91. Solaro RJ, Rarick HM: Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ. Res. 83, 471-480 (1998).
92. Rice JJ, Wang F, Bets DM, De Tombe PP: Approximate model of cooperative activation and crossbridge cycling in cardiac muscle using ordinary differential equations. Biophys. J. 95, 2368-2390 (2008).
93. Schneider NS, Shimayoshi T, Amano A, Matsuda T: Mechanism of the Frank-Starling law - a simulation study with a novel cardiac muscle contraction model that includes titin and croponin I. J. Mol. Cell Cardiol. 41, 522-536 (2006).
94. Niederer SA, Hunter PJ, Smith NP: A quantitative analysis of cardiac myocyte relaxation: a simulation study. Biophys. J. 90, 1697-1722 (2006).
95. Feit TS: Diastolic pressure-volume relations and distribution of pressure and fiber extension across the wall of a model left ventricle. Biophys. J. 128, 143-166 (1979).
96. Bovendeerd PH, Arts T, Huyghe JM, van Campen DH, Reneman RS: Dependence of local left ventricular wall mechanics on myocardial fiber orientation: a model study. J. Biomech. 25, 1129-1140 (1992).
97. Nielsen PM, Le Crice IJ, Smaill BH, Hunter PJ: Mathematical model of geometry and fibrous structure of the heart. Art. J. Physiol. 260, H1365-H1378 (1991).
98. Fernandez JW, Mithraratne P, Thrupp SF, Tawhai MH, Hunter PJ: Anatomically based geometric modelling of the musculo-skeletal system and other organs. Biomech. Model Mechanobiol. 2, 139-155 (2004).
99. Kerckhoffs RC, Faris OP, Bovendeerd PH et al.: Electromechanics of paced left ventricle simulated by straightforward mathematical model: comparison with experiments. Am. J. Physiol. Heart Circ. Physiol. 289, H1889-H1897 (2005).
100. Usyk TP, LeGrice IJ, McCulloch AD: Computational model of three-dimensional cardiac electromechanics. Comput. Visual Sci. 4, 249-257 (2002).
101. Hunter PJ, McCulloch AD, ter Keurs HE: Modelling the mechanical properties of cardiac muscle. Prog. Biophys. Mol. Biol. 69, 289-331 (1998).
102. Ashikaga H, Coppola BA, Hopenfeld B, Leifer ES, McVeigh ER, Omens JH: Transmittal dispersion of myofiber mechanics: implications for electrical heterogeneity in vivo. J. Am. Coll. Cardiol. 49, 909-916 (2007).
103. Vetter FJ, McCulloch AD: Three-dimensional analysis of regional cardiac function: a model of rabbit ventricular anatomy. Prog. Biophys. Mol. Biol. 69, 157-183 (1998).
104. Burton RA, Plank G, Schneider JE et al.: Three-dimensional models of individual cardiac histoanatomy: tools and challenges. Ann. NY Acad. Sci. 1080, 301-319 (2006).
105. Plotkowiak M, Rodriguez B, Plank G et al.: High performance computer simulations of cardiac electrical function based on high resolution mri datasets. In: Lecture Notes in Computer Science. Springer Berlin, Heidelberg, Germany, 571-580 (2008).
106. Hsu EW, Muzikant AL, Matulevicius SA, Penland RC, Henriquez CS: Magnetic resonance myocardial fiber-orientaion mapping with direct histological correlation. Am. J. Physiol. 274, H1627-H1634 (1998).
107. Scollan DF, Holmes A, Winslow R, Forder J: Histological validation of myocardial microstructure obtained from diffusion tensor magnetic resonance imaging. Am J. Physiol. 275, H2308-H2318 (1998).
108. Helm PA, Younes L, Beg MF et al.: Evidence of structural remodeling in the dyssynchronous failing heart. Circ. Res. 98, 125-132 (2006).
109. Ordas S, Frangi A: automatic quantitative analysis of myocardial wall motion and thickening from long-and short-axis cine MRI studies. Conf. Proc. IEEE Eng. Med. Biol. Soc. 7, 7028-7031 (2005).
110. Sermesant M, Delingette H, Ayache N: An electromechanical model of the heart for image analysis and simulation. IEEE Trans. Med. Imaging 25, 612-625 (2006).
111. Demer LL, Yin FC: Passive biaxial mechanical properties of isolated canine myocardium. J. Physiol. 339, 615-630 (1983).
112. Dokos S, Legrice I, Smaill B, Kar J, Young A: A triaxial-measurement shear-test device for soft biological tissues. J. Biomech. Eng. 122, 471-478 (2000).
113. Halperin HR, Chew PH, Weisfeldt ML, Sagawa K, Humphrey JD, Yin FC. Transverse stiffness: a method for estimation of myocardial wall stress. Circ. Res. 61, 695-703 (1987).
114. Vetter F, McCulloch A: Three-dimensional stress and strain in passive rabbit left ventricle: a model study. Ann. Biomed. Eng. 28, 781-792 (2006).
115. Nickerson D, Smith N, Hunter P: New developments in a strongly coupled cardiac electromechanical model. Europace 7 (Suppl. 2), 118-127 (2005).
116. Jie X, Gurev V, Trayanova N: Mechanisms of mechanically-induced spontaneous arrhythmias in acute regional ischemia. Proceedings of Heart Rhythm 2008. 29th Annual Scientific Sessions. San Francisco, CA, 14 May 2008.
117. Gurev V, Blake RC, Trayanova NA: Myocardial stretch alters the pattern of post-shock activity. Heart Rhythm 3, S310-S311 (2006).
118. Nash MP, Panfilov AV: Electromechanical model of excitable tissue to study reentrant cardiac arrhythmias. Prog. Biophys. Mol. Biol. 85, 501-522 (2004).
119. Frangi AF, Niessen WJ, Viergever MA: Three-dimensional modeling for functional analysis of cardiac images: a review. IEEE Trans. Med. Imaging 20, 2-25 (2001).
120. Guccione JM, Moonly SM, Moustakidis P et al.: Mechanism underlying mechanical dysfunction in the border zone of left ventricular aneurysm: a finite element model study. Ann. Thorac. Surg. 71, 654-662 (2001).
121. Dang AB, Guccione JM, Mishell JM et al.: Akinetic myocardial infarcts must contain contracting myocytes: finite-element model study. Am. J. Physiol. Heart Circ. Physiol. 288, H1844-H1850 (2005).
122. Usyk TP, McCulloch AD: Electromechanical model of cardiac resynchronization in the dilated failing heart with left bundle branch block. J. Electrocardiol. 36(Suppl.), 57-61 (2003).
123. Winters J, Stark L: Muscle models: what is gained and what is lost by varying model complexity. Biol. Cybern. 55, 403-420 (1987).
124. Hunter PJ, Borg TK: Integration from proteins to organs: the Physiome Project. Nat. Rev. Mol. Cell Biol. 4, 237-243 (2003).
125. Noble D: Modeling the heart - from genes to cells to the whole organ. Science 295, 1678-1682 (2002).
126. Austin TM, Hooks DA, Hunter PJ et al.: Modeling cardiac electrical activity at the cell and tissue levels. Ann. NY Acad. Sci. 1080, 334-347 (2006).
127. Shimizu W, Antzelevitch C: Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98, 2314-2322 (1998).
128. Kerckhoffs RC, Bovendeerd PH, Kotte JC, Prinzen FW, Smits K, Arts T: Homogeneity of cardiac contraction despite physiological asynchrony of depolarization: a model study. Ann. Biomed. Eng. 31, 536-547 (2003).